# Jay Keasling
Meilleurs épisodes de podcast
Actualisé:
Jay D. Keasling is a Professor of Chemical engineering and Bioengineering at the University of California, Berkeley. He is also Associate Laboratory Director for Biosciences at the Lawrence Berkeley National Laboratory and chief executive officer of the Joint BioEnergy Institute. He is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering.
Energy disruptors: Jay Keasling on plant-based fuels
Jay Keasling, a pioneer in the field of synthetic biology, grew up on a farm in Nebraska where his father raised corn. He decided to apply his past to what he’d been doing for years, engineering microbes to produce chemicals. He’s turned his attention to solving the world’s energy crisis, using pla…
Semi-Synthetic Artemisinin - The Beginning of the SynthBio Revolution? - An Interview with Jay Keasling
Artemisinin is a front line anti-malarial drug which was derived from the sweet wormwood plant. ‘Growing on trees’ however, isn’t all it’s cracked up to be and the supply could be unpredictable. Professor Jay Keasling, using synthetic biology techniques, had
Jay Keasling
Jay Keasling is a professor in the College of Chemistry at the University of California at Berkeley, where he runs the Keasling lab. He’s also the CEO of the Joint BioEnergy Institute, and has been involved in several startups. His conversation with Nature Biotechnology covers growing up on the fam…
51. Future of SynBio w/ Jay Keasling - Professor @ Berkeley
Jay Keasling is the Philomathia Professor of Alternative Energy at the University of California, Berkeley in the Departments of Bioengineering and Chemical and Biomolecular Engineering, senior faculty scientist at Lawrence Berkeley National Laboratory, and Chief Executive Officer of the Joint BioEn…
Developing foundational tools for engineering metabolism inside cells to solve important societal problems.
Jay Keasling, the CEO of the Joint BioEnergy Institute (JBEI). He is also a Professor in the Department of Chemical & Biomolecular Engineering and also the Department of Bioengineering at the University of California, Berkeley.. He's also a Senior Faculty Scientist @ Lawrence Berkeley National Labo…
The future of culinary mycology: A conversation with Vayu Hill-Maini
Along with bacteria and yeast, fungi play an important role in fermentation. We primarily think of Aspergillus oryzae and Rhizopus oryzae, but there are a number of other fungi that are used in food production, including Aspergillus sojae, Monascus purpureus. We wanted to talk to Dr. Vayu Hill-Main…
🧬 Rafael Rosengarten - Part 1 | From Salt Marsh to Biotech CEO | Snorkeling into Science | Choosing Marine Biology Over Cooking on a Mediterranean Yacht
Part 1 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for every target, drug, and patient using a combination of precision oncology, RNA, and AI.
Rafael, a biomedical research veteran, combines academic exce…
🧬 Rafael Rosengarten - Part 2 | From Marine Biology to Synthetic Biology | Building Biofuel Tools at JBEI | When Academic Labs Embrace Entrepreneurship
🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success.
🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000…
Engineering the P450 Workhorse to Secure Supply Chains and Save Endangered Trees with Maria Astolfi
What if we could secure critical supply chains through bioengineering? What if the vaccines protecting millions worldwide didn't require harvesting 10,000 trees annually from Chilean mountains? Maria Astolfi is tackling this exact challenge through groundbreaking work with P450 enzymes.Growing up s…
Episode 171 - Amin & Chad - Resvita Bio CEO & CTO
In this episode of The BioHub Podcast, Max sits down with Amin Zargar, CEO of ResVita Bio, and Chad Miller, the company’s Chief Technology Officer.
ResVita is developing a new class of treatments for skin diseases using engineered bacteria to deliver continuous protein therapy directly on the skin…
MOTEUR DE RECHERCHE DE PODCASTS
Vous pouvez utiliser notre site Web pour rechercher des podcasts3,824,399et des épisodes195,746,258par personnes, lieux ou sujets.
Investir dans le savoir offre le meilleur rendement, c'est pourquoi j'écoute des podcasts.
‐ Benjamin "Llamacorn" Franklin
MODIFIER
Merci de nous avoir aidé à tenir la base de données de podcasts à jour.
